Hercules Capital Price to Sales Ratio 2010-2024 | HTGC
Historical PS ratio values for Hercules Capital (HTGC) over the last 10 years. The current P/S ratio for Hercules Capital as of November 13, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Hercules Capital P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-11-12 |
19.80 |
|
6.25 |
| 2024-09-30 |
19.64 |
$3.17 |
6.20 |
| 2024-06-30 |
19.92 |
$3.18 |
6.25 |
| 2024-03-31 |
17.53 |
$3.23 |
5.43 |
| 2023-12-31 |
15.43 |
$3.22 |
4.78 |
| 2023-09-30 |
14.75 |
$3.17 |
4.65 |
| 2023-06-30 |
12.91 |
$3.03 |
4.27 |
| 2023-03-31 |
10.86 |
$2.79 |
3.89 |
| 2022-12-31 |
10.81 |
$2.57 |
4.20 |
| 2022-09-30 |
9.14 |
$2.41 |
3.79 |
| 2022-06-30 |
10.30 |
$2.36 |
4.37 |
| 2022-03-31 |
13.38 |
$2.32 |
5.78 |
| 2021-12-31 |
11.94 |
$2.36 |
5.05 |
| 2021-09-30 |
11.69 |
$2.41 |
4.85 |
| 2021-06-30 |
11.74 |
$2.43 |
4.84 |
| 2021-03-31 |
10.78 |
$2.50 |
4.32 |
| 2020-12-31 |
9.47 |
$2.57 |
3.68 |
| 2020-09-30 |
7.38 |
$2.60 |
2.84 |
| 2020-06-30 |
6.50 |
$2.64 |
2.46 |
| 2020-03-31 |
4.59 |
$2.73 |
1.68 |
| 2019-12-31 |
8.18 |
$2.67 |
3.07 |
| 2019-09-30 |
7.61 |
$2.60 |
2.93 |
| 2019-06-30 |
7.11 |
$2.49 |
2.86 |
| 2019-03-31 |
6.85 |
$2.35 |
2.91 |
| 2018-12-31 |
5.84 |
$2.32 |
2.52 |
| 2018-09-30 |
6.78 |
$2.30 |
2.95 |
| 2018-06-30 |
6.37 |
$2.31 |
2.76 |
| 2018-03-31 |
5.95 |
$2.33 |
2.56 |
| 2017-12-31 |
6.28 |
$2.32 |
2.71 |
| 2017-09-30 |
6.04 |
$2.36 |
2.56 |
| 2017-06-30 |
6.05 |
$2.41 |
2.51 |
| 2017-03-31 |
6.75 |
$2.42 |
2.79 |
| 2016-12-31 |
6.17 |
$2.40 |
2.57 |
| 2016-09-30 |
5.79 |
$2.32 |
2.50 |
| 2016-06-30 |
5.19 |
$2.37 |
2.19 |
| 2016-03-31 |
4.89 |
$2.30 |
2.12 |
| 2015-12-31 |
4.83 |
$2.26 |
2.13 |
| 2015-09-30 |
3.89 |
$2.28 |
1.71 |
| 2015-06-30 |
4.34 |
$2.20 |
1.97 |
| 2015-03-31 |
4.94 |
$2.21 |
2.23 |
| 2014-12-31 |
5.33 |
$2.28 |
2.34 |
| 2014-09-30 |
5.08 |
$2.25 |
2.26 |
| 2014-06-30 |
5.57 |
$2.34 |
2.38 |
| 2014-03-31 |
4.74 |
$2.36 |
2.01 |
| 2013-12-31 |
5.42 |
$2.37 |
2.29 |
| 2013-09-30 |
4.95 |
$2.37 |
2.08 |
| 2013-06-30 |
4.44 |
$2.19 |
2.03 |
| 2013-03-31 |
3.82 |
$2.11 |
1.81 |
| 2012-12-31 |
3.40 |
$2.01 |
1.69 |
| 2012-09-30 |
3.29 |
$1.94 |
1.69 |
| 2012-06-30 |
3.31 |
$1.88 |
1.76 |
| 2012-03-31 |
3.17 |
$1.88 |
1.69 |
| 2011-12-31 |
2.64 |
$1.85 |
1.43 |
| 2011-09-30 |
2.33 |
$1.82 |
1.28 |
| 2011-06-30 |
2.81 |
$1.83 |
1.53 |
| 2011-03-31 |
2.87 |
$1.76 |
1.63 |
| 2010-12-31 |
2.65 |
$1.66 |
1.60 |
| 2010-09-30 |
2.54 |
$1.68 |
1.51 |
| 2010-06-30 |
2.27 |
$1.74 |
1.31 |
| 2010-03-31 |
2.56 |
$1.89 |
1.36 |
| 2009-12-31 |
2.46 |
$2.16 |
1.14 |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Finance - SBIC & Commercial |
$3.217B |
$0.461B |
|
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|
